San Francisco Bay Area biotech stories.
Monday, March 7, 2011
Exelixis to sell 14.4 million shares
Striking while its drug is hot, Exelixis Inc. could raise around $160 million by selling nearly 14.4 million shares from a previous shelf registration of stock.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)